Featured on the cover of Nature Biotechnology: Immune Cells Engineered to Signal when Cancer is Detected
March 1, 2019
From Stanford News
Hanae Armitage
Stanford scientists were able to engineer immune cells known as macrophages to detect and flag cancer in mice. The researchers hope the technique can be used for early cancer diagnostics in humans.
Immune cells imbued with the power to detect and reveal tumors could be a new method of diagnosing cancer, according to a study from the Stanford University School of Medicine.
The research, performed in mice, involved modifying a specific class of immune cells to patrol the body for cancer and send a signal through blood or urine when they found trouble.
Read the Nature Biotechnology article
View NBT cover
Read the Stanford Press release
Read the Scope Blog article
Read the Chemical & Engineering News article
Read the Endpoints News article
Read the Ludwig Cancer Research article